{"id":"W7116955310","doi":"10.1016/j.annonc.2025.12.017","title":"Datopotamab deruxtecan versus chemotherapy in previously treated inoperable/metastatic hormone receptor-positive, HER2-negative breast cancer: final overall survival analysis of the phase III TROPION-Breast01 study","year":2025,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Memorial Sloan-Kettering Cancer Center; Daiichi Sankyo Europe; AstraZeneca","keywords":"Clinical endpoint; Chemotherapy; Overall survival; Phases of clinical research; Chemotherapy regimen; Hormone therapy; Hormone","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003063398,0.000975493,0.001579207,0.0004015463,0.0002108444,0.0007453014,0.0006139004,0.0006798769,0.001810993],"category_scores_gemma":[0.001364546,0.0003438419,0.001586084,0.0003772631,0.000610407,0.0005557595,0.0003329072,0.00162489,0.0002801423],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009077049,"about_ca_system_score_gemma":0.0008643582,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007837482,"about_ca_topic_score_gemma":0.003046204,"domain_scores_codex":[0.998913,0.0007852046,0.00004998355,0.00009880042,0.00006445358,0.00008847978],"domain_scores_gemma":[0.9989736,0.0002660948,0.0003028226,0.00008822688,0.00005082336,0.0003184452],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9331427,0.01037859,0.01220655,0.0004734814,0.00237503,0.00006341845,0.0001135062,0.00148121,0.006865637,0.00009040007,0.001086408,0.03172309],"study_design_scores_gemma":[0.4891805,0.446466,0.05320553,0.00007087336,0.003116221,0.0002372948,0.00008773638,0.001854832,0.003035916,0.0002062431,0.00250624,0.00003259701],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9958199,0.001986998,0.0001657546,0.0001708349,0.0000572548,0.0004722476,0.0005403086,0.00001891182,0.0007677572],"genre_scores_gemma":[0.9954587,0.001209729,0.0003736001,0.000289,0.0001058291,0.0005168975,0.001060358,0.00001085252,0.000975017],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003063398,"threshold_uncertainty_score":0.01620096,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09547552410677164,"score_gpt":0.4617903217570697,"score_spread":0.3663147976502981,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}